Evaluating AI Models’ Reliability, Transparency, and Bias in Clinical or Administrative Workflows

While AI is a huge buzz topic in healthcare right now, it’s not above being inspected and evaluated. Like everything else in healthcare, it’s only worth keeping and using if it’s properly achieving the results we are seeking without tampering with other parts of your organization. So what does the evaluation process look like for AI models?

We reached out to our brilliant Healthcare IT Today Community to ask — how do you evaluate the reliability, transparency, and bias of AI models used in clinical or administrative workflows? The following are their responses.

Harshit Jain, Founder and Global CEO at Doceree

Evaluating AI reliability in healthcare requires rigorous, ongoing assessment across multiple dimensions.

• Clinical Validation: AI models delivering treatment information, adherence messaging, or patient education must pull from verified medical databases and undergo regular content audits by clinical teams to ensure accuracy and relevance

• Transparency: Models should provide clear attribution—showing why specific content is surfaced and which data signals triggered it; black-box algorithms have no place in clinical environments

• Bias Detection: Regular audits must assess whether AI recommendations disproportionately favor certain patient populations, treatment options, or pharmaceutical brands; performance metrics should be stratified by demographics, conditions, and settings

• Continuous Monitoring: Establish feedback loops where providers flag inaccuracies, track engagement patterns, and measure clinical outcomes tied to AI-driven interventions

Dr. Scott Schell, Chief Medical Officer at Cognizant

Evaluation should be conducted in accordance with established clinical and operational endpoints.

• Local Validation: Models must be assessed on the organization’s own data and workflows; vendor benchmarks are useful only as a starting point

• Operational Calibration: Accuracy metrics are necessary but insufficient; stability over time, adaptive calibration, and the costs of false alerts matter to frontline teams

• Transparency: Outputs must include clear provenance, specifically including which inputs were used, what the model was trained on, and model limitations identified during validation

• Bias Monitoring: Evaluate across meaningful clinical subgroups and watch for performance drift that correlates with data missingness or demographic proxies; an AI component that cannot be evaluated against practical decision points is not operationally reliable

Elevsis Delgadillo, SVP, Customer Success at KeenStack

To evaluate reliability, transparency, and bias, organizations need to start by understanding the data behind the model. Clear documentation and transparency around what information is being used and what factors are influencing decisions are essential. From there, models should be tested across different patient groups and continuously monitored after deployment to make sure they’re not introducing unintended bias.

Hasan Jilani, Director of Product Marketing at Deepgram

Reliability starts with defining what “works” in real-world workflow terms, not just model benchmarks. You measure latency, uptime, and task completion rates alongside classic accuracy metrics for speech and voice systems. The most meaningful indicators are things like percent of interactions completed without human intervention, call abandonment, time-to-resolution, and error recovery when something goes wrong, in a call center or scheduling flow.

Noisy lobbies, mobile calls, speakerphone audio, overlapping speech, heavy jargon, and rapid code-switching between languages are environments that actually break systems – so performance across these scenarios must be evaluated too. For clinical documentation, you validate on specialty-specific vocabulary and the downstream impact, such as whether generated summaries reduce rework, improve note completeness, and avoid hallucinated details.

A mix of instrumentation and governance is required for transparency and bias. From input to output, you want traceability – including logs that show what the system heard, what it decided, and why it escalated. Organizations increasingly expect explainability at the right layer, not a vague confidence score, but a concrete rationale and references back to source data, for clinical or administrative decisions.

Bias testing should be baked into evaluation – performance by age, gender, accent, language, disability status when available, and proxies like geography or socioeconomic context. Then you monitor for drift after deployment. This is because the model that was fair in testing can become unfair as patient populations shift, audio devices change, or the organization expands into new regions.

Continuous evaluation with guardrails must be the platinum standard. If error rates spike for a cohort or a site, you catch it early, route to human review, and have a clear path to retrain, fine-tune, or roll back.

Robert Stewart, Chief Technology Officer at Arbital Health

Variability and uncertainty are long-standing realities in healthcare. As major AI players release new healthcare tools, they will become more deeply embedded in operational and clinical decision-making. However, the industry must clearly define how that variability is understood, governed, and communicated. Through established safeguards and professional judgment, clinicians already account for false positives, diagnostic drift, and the need for repeat testing. AI systems, especially large language models, introduce a different kind of non-determinism that cannot be managed in the same way.

Even with approaches like retrieval-augmented generation (RAG), these models can produce materially different outputs from the same underlying data, creating risk if their limitations aren’t explicit. For the healthcare IT community, the priority is not eliminating variability, but designing AI systems with transparency, traceability, and appropriate guardrails built by human expertise. That way, users remain firmly in control when decisions carry real clinical and financial consequences.

Beth Godsey, General Manager of Tendo Insights at Tendo

Reliability is evaluated by testing whether a model consistently identifies the right situations in real-world workflows, not just whether it performs well in retrospective analyses. Transparency matters at the point of use: teams need to understand why a signal is appearing and what action it’s meant to prompt. Bias is assessed by examining performance across different patient populations, care settings, and service lines to ensure signals are not systematically missing or misclassifying certain groups. Ongoing monitoring is critical, since changes in workflows, documentation, or care patterns can quietly degrade model performance over time.

Firoze Lafeer, SVP of Data Engineering at Revecore

Evaluating AI models in healthcare requires continuous attention to reliability, transparency, and fairness both before and after deployment. Reliability extends beyond traditional accuracy metrics. It involves assessing performance in real-world conditions and tracking outcomes that align with operational and clinical goals, such as workflow efficiency, denial reduction, or timeliness of care. Robust back-testing, simulation, and post-deployment monitoring help identify performance degradation and ensure models remain effective over time.

Transparency is equally critical. Explainable models that clearly articulate the rationale behind their outputs are more likely to earn trust from clinicians, administrators, and other stakeholders. When users understand how and why a recommendation is generated, they are better equipped to apply it appropriately.

To address bias, comprehensive fairness assessments are necessary. This includes analyzing performance across different patient populations and use cases to identify disparities and make corrective adjustments. Bias mitigation is not a one-time exercise, but an ongoing responsibility as data, workflows, and care environments change.

Jessica Hammond, Senior Director of Product Management – GenAI at Protegrity

Observability is key to any AI model implementation. A key criterion of passing audits and meeting regulations comes down to explainability. Observability empowers organizations to meet the explainability criteria, but it alone is not sufficient. Explainability is difficult in indeterministic systems. It requires a shift from thinking ‘why did it output that’ to ‘how can I prove its output to be true and verifiable.’

Observability includes end-to-end logging, metric monitoring, traceability, and feedback loops. This information enables explainability, which requires local and global explanations in human-readable formats.

There are tricks to building agentic systems with LLMs that assist the enterprise in arriving at deterministic output from workflows. Those can include:

• Tool-Centric Design: Routing tasks to structured tools and constraining LLMs to orchestration and narration

• Strict Schemas and Contracts: Use rigid output formats and reject/re-ask on schema violations

• Multi-Step Reasoning: Tasks are broken into explicit steps that can be validated at each turn

• Retrieval-Grounded Generation: Force the agent to operate only over retrieved, versioned knowledge bases with citations

• Human in the Loop: Human review of conclusions, outputs, and citation accuracy prior to publication

Ben Scharfe, EVP for AI at Altera Digital Health
Evaluation must be continuous, not a one-time ‘seal of approval.’ This means continuous reconciliation between manual, expert outputs versus those produced by AI. Transparency is measured by the ‘explainability’ of the output, most easily achieved by logging and presenting the AI’s reasoning process and input data points. Can a clinician see why a suggestion was made?

To combat bias, health systems should prioritize vendors who train on diverse, representative datasets and provide clear documentation on performance across different sub-populations. Reliability is ultimately proven through parallel testing in live workflows before full deployment, ensuring the AI performs consistently across various specialties and accents.

Shay Perera, Co-Founder & CTO at Navina
Evaluating reliability requires assessing models in real-world clinical contexts, not just retrospective datasets, and comparing performance against human professionals on relevant tasks to ensure they hold up under realistic conditions. Transparency means designing models that are explainable and interpretable by clinicians, not hidden ‘black boxes.’ Bias must be continually assessed and mitigated by training on diverse datasets that represent the full spectrum of patient demographics and care scenarios, and by monitoring outputs for unintended disparities, while also creating structured feedback loops with clinicians and users to correct issues as they arise.

Jared Hamilton, Cyber Managing Director at Crowe LLP
Our evaluation starts with assessing the solution around potential bias in the data used to train the model and whether that could influence clinical or operational outcomes, which requires asking detailed, targeted questions of vendors about how their AI models are developed and validated. Transparency around model training, data sources, and how outputs are generated is critical.

We also place strong emphasis on data protection to ensure organizational data is properly secured, clearly separated, and not intermixed with external datasets without explicit approval. Vendor certifications such as HITRUST, or similar frameworks that account for emerging AI regulatory considerations, are helpful indicators of maturity, though they are part of a broader due diligence process rather than a substitute for it